Literature DB >> 10963735

Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: a possible explanation for the increased cardiovascular risk in these patients.

G Clermont1, S Lecour, J Lahet, P Siohan, C Vergely, D Chevet, G Rifle, L Rochette.   

Abstract

OBJECTIVE: The high incidence of cardiovascular diseases in chronic renal failure (CRF) and hemodialyzed (HD) patients is now well established and the involvement of oxidative stress has been hypothesized in these phenomena. The aim of our study was to evaluate the level of oxidative stress in healthy controls (CTL) compared with CRF and HD patients before (pre-HD) and after (post-HD) the dialysis session, carried out on a high biocompatible polyacrylonitrile membrane AN69.
METHODS: Several indicators of the extracellular redox status were evaluated in plasma. The ascorbyl free radical (AFR) was directly measured using electron spin resonance spectroscopy (ESR) and expressed with respect to the vitamin C level to obtain a direct index of oxidative stress. Indirect plasma parameters such as vitamin E, thiol and uric acid levels were also quantified. The plasma antioxidant status (PAS) was evaluated by the allophycocyanin test. Nitric oxide (NO) stable-end metabolites: nitrites and nitrates (NO(x)), were measured in plasma.
RESULTS: In CRF patients, vitamin C and thiol levels were low, and the AFR/vitamin C ratio high compared with the CTL. On the other hand, PAS and uric acid levels were shown to be higher in CRF patients. After the dialysis session, vitamin C level decreased and AFR/vitamin C ratio increased. The thiol levels were shown to be increased, in return PAS and uric acid levels were significantly lower after the dialysis session. NO(x) levels rose during CRF, but were significantly decreased after the dialysis procedure. No differences in vitamin E status were observed between CTL, CRF and HD patients.
CONCLUSION: Our study demonstrates that profound disturbances in the extracellular redox system occur during the course of chronic renal failure and hemodialysis, and may provide an explanation for the cardiovascular complications in these patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10963735     DOI: 10.1016/s0008-6363(00)00117-6

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  23 in total

1.  Oxidative stress, superoxide production, and apoptosis of neutrophils in dogs with chronic kidney disease.

Authors:  Adriana Carolina Rodrigues Almeida Silva; Breno Fernando Martins de Almeida; Carolina Soares Soeiro; Wagner Luis Ferreira; Valéria Marçal Félix de Lima; Paulo César Ciarlini
Journal:  Can J Vet Res       Date:  2013-04       Impact factor: 1.310

2.  Serum bilirubin links UGT1A1*28 polymorphism and predicts long-term cardiovascular events and mortality in chronic hemodialysis patients.

Authors:  Ying-Hwa Chen; Szu-Chun Hung; Der-Cherng Tarng
Journal:  Clin J Am Soc Nephrol       Date:  2011-03       Impact factor: 8.237

3.  Use of colorimetric test strips for monitoring the effect of hemodialysis on salivary nitrite and uric acid in patients with end-stage renal disease: a proof of principle.

Authors:  Timothy M Blicharz; David M Rissin; Michaela Bowden; Ryan B Hayman; Christopher DiCesare; Jasvinder S Bhatia; Nerline Grand-Pierre; Walter L Siqueira; Eva J Helmerhorst; Joseph Loscalzo; Frank G Oppenheim; David R Walt
Journal:  Clin Chem       Date:  2008-08-01       Impact factor: 8.327

4.  Length polymorphism in heme oxygenase-1 and cardiovascular events and mortality in hemodialysis patients.

Authors:  Yu-Hsin Chen; Szu-Chun Hung; Der-Cherng Tarng
Journal:  Clin J Am Soc Nephrol       Date:  2013-06-27       Impact factor: 8.237

5.  Uric Acid and Coronary Artery Disease, Two Sides of a Single Coin: A Determinant of Antioxidant System or a Factor in Metabolic Syndrome.

Authors:  Babak Bagheri; Mehryar Zargari; Fatemeh Meshkini; Kolsoum Dinarvand; Vahid Mokhberi; Soheil Azizi; Mehdi Rasouli
Journal:  J Clin Diagn Res       Date:  2016-02-01

6.  Heme oxygenase 1 expression in young uremic patients on hemodialysis.

Authors:  Zoltán Maróti; Ilona Németh; Sándor Túri; Eszter Karg; Péter Ugocsai; Emoke Endreffy
Journal:  Pediatr Nephrol       Date:  2004-02-24       Impact factor: 3.714

7.  Acute effects of hemodialysis on oxidative stress parameters in chronic uremic patients: comparison of two dialysis membranes.

Authors:  H Ibrahim Varan; Belda Dursun; Evrim Dursun; Tomris Ozben; Gultekin Suleymanlar
Journal:  Int J Nephrol Renovasc Dis       Date:  2010-04-12

8.  Effect of reuse of polysulfone membrane on oxidative stress during hemodialysis.

Authors:  P Ramakrishna; E Prabhakar Reddy; M M Suchitra; A R Bitla; P V Srinivasa Rao; V Sivakumar
Journal:  Indian J Nephrol       Date:  2012-05

9.  Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.

Authors:  María Jesús Izquierdo; Mónica Cavia; Pilar Muñiz; Angel L M de Francisco; Manuel Arias; Javier Santos; Pedro Abaigar
Journal:  BMC Nephrol       Date:  2012-11-27       Impact factor: 2.388

10.  Is There a Correlation between Vitamin C Status and Catecholamines Concentrations in Hemodialysis Patients?

Authors:  Isaline Coquet; Jean-Marc Doise; Jean-Claude Guilland; Catherine Vergely; Christiane Mousson; Luc Rochette
Journal:  Int J Biomed Sci       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.